Lactoferrin and host defence: An overview of its immuno-modulating and anti-inflammatory properties

BioMetals

Volumn 17, Issue 3, 2004, Pages 225-229

  Legrand, Dominique ^a   Elass, Elisabeth ^a   Pierce, Annick ^a   Mazurier, Joël ^a  

^a UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

Author keywords

Immunity; Inflammation; Lactoferrin

Indexed keywords

LACTOFERRIN; TRANSFERRIN;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; BLOOD; CELL LEVEL; CELL MATURATION; CELL MIGRATION; HOST RESISTANCE; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFLAMMATION; NEUTROPHIL; PROTEIN SECRETION; REVIEW; SEPTIC SHOCK;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; HUMANS; IMMUNE SYSTEM; IMMUNOLOGIC FACTORS; LACTOFERRIN;

EID: 3342888949     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BIOM.0000027696.48707.42     Document Type: Review

References (57)

1. Afeltra A, Caccavo D, Ferri GM et al. 1997 Expression of lactoferrin on human granulocytes: analysis with polyclonal and monoclonal antibodies. Clin Exp Immunol 109, 279-285.
2. Appelmelk BJ, An YQ, Geerts M et al. 1994 Lactoferrin is a lipid A-binding protein. Infect Immun 62, 2628-2632.
3. Baveye S, Elass E, Fernig DG, Blanquart C, Mazurier J, Legrand D. 2000a Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex. Infect Immun 68, 6519-6525
4. Baveye S, Elass E, Mazurier J, Legrand D. 2000b Lactoferrin inhibits the binding of lipopolysaccharides to L-selectin and subsequent production of reactive oxygen species by neutrophils. FEBS Lett 469, 5-8.
5. Bennett RM, Kokocinski T. 1978 Lactoferrin content of peripheral blood cells. Br J Haematol 39, 509-521.
6. Britigan BE, Lewis TS, Waldschmidt M, McCormick ML, Krieg AM. 2001 Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells. J Immunol 167, 2921-2928.
7. Broxmeyer HE, Williams DE, Hangoc G et al. 1987 The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors. Blood Cells 13, 31-48.
8. Damiens E, Mazurier J, el Yazidi I et al. 1998 Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells. Biochim Biophys Acta 1402, 277-287.
9. Deriy LV, Chor J, Thomas LL. 2000 Surface expression of lactoferrin by resting neutrophils. Biochem Biophys Res Commun 275, 241-246.
10. Dhennin-Duthille I, Masson M, Damiens E, Fillebeen C, Spik G, Mazurier J. 2000 Lactoferrin upregulates the expression of CD4 antigen through the stimulation of the mitogen-activated protein kinase in the human lymphoblastic T Jurkat cell line. J Cell Biochem 79, 583-593.
11. Elass E, Masson M, Mazurier J, Legrand D. 2002 Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells. Infect Immun 70, 1860-1866.
12. Elass-Rochard E, Legrand D, Salmon V et al. 1998 Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide- binding protein. Infect Immun 66, 486-491.
13. Elass-Rochard E, Roseanu A, Legrand D et al. 1995 Lactoferrin- lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to E. coli 055B5 lipopolysaccharide. Biochem J 312, 839-845.
14. Elrod KC, Moore WR, Abraham WM, Tanaka RD. 1997 Lactoferrin, a potent tryptase inhibitor, abolishes late-phase airway responses in allergic sheep. Am J Respir Crit Care Med 156, 375-381.
15. Fillebeen C, Dehouck B, Benaïssa M, Dhennin-Duthille I, Cecchelli R, Pierce A. 1999 Tumor necrosis factor-alpha increases lactoferrin transcytosis through the blood-brain barrier. J Neurochem 73, 2491-2500.
16. Fillebeen C, Ruchoux MM, Mitchell V, Vincent S, Benaïssa M, Pierce A. 2001 Lactoferrin is synthesized by activated microglia in the human substantia nigra and its synthesis by the human microglial CHME cell line is upregulated by tumor necrosis factor alpha or 1-methyl-4-phenylpyridinium treatment. Brain Res Mol Brain Res 96, 103-113.
17. Frydecka I, Zimecki M, Bocko D et al. 2002 Lactoferrin-induced up-regulation of zeta (zeta) chain expression in peripheral blood T lymphocytes from cervical cancer patients. Anticancer Res 22, 1897-1901.
18. Gahr M, Speer CP, Damerau B, Sawatzki G. 1991 Influence of lactoferrin on the function of human polymorphonuclear leukocytes and monocytes. J Leukoc Biol 49, 427-433.
19. Griffiths CE, Cumberbatch M, Tucker SC et al. 2001 Exogenous topical lactoferrin inhibits allergen-induced Langerhans cell migration and cutaneous inflammation in humans. Br J Dermatol 144, 715-725.
20. Guillen C, McInnes IB, Vaughan DM et al. 2002 Enhanced Th1 response to Staphylococcus aureus infection in human lactoferrin-transgenic mice. J Immunol 168, 3950-3957.
21. Haversen L, Ohlsson BG, Hahn-Zoric M, Hanson LA, Mattsby-Baltzer I. 2002 Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappaB. Cell Immunol 220, 83-95.
22. He S, McEuen AR, Blewett SA et al. 2003 The inhibition of mast cell activation by neutrophil lactoferrin: uptake by mast cells and interaction with tryptase, chymase and cathepsin G. Biochem Pharmacol 65, 1007-1015.
23. van Hooijdonk AC, Kussendrager KD, Steijns JM. 2000 In vivo antimicrobial and antiviral activity of components in bovine milk and colostrum involved in non-specific defence. Br J Nutr 84, S127-134.
24. Houghton MR, Gracey M, Burke V, Bottrell C, Spargo RM. 1985 Breast milk lactoferrin levels in relation to maternal nutritional status. J Pediatr Gastroenterol Nutr 4, 230-233.
25. Kai K, Komine K, Komine Y et al. 2002 Lactoferrin stimulates A Staphylococcus aureus killing activity of bovine phagocytes in the mammary gland. Microbiol Immunol 46, 187-194.
26. Kijlstra A, Jeurissen SH. 1982 Modulation of classical C3 convertase of complement by tear lactoferrin. Immunology 47, 263-270.
27. Kimber I, Cumberbatch M, Dearman RJ, Headon DR, Bhushan M, Griffiths CE. 2002 Lactoferrin: influences on Langerhans cells, epidermal cytokines, and cutaneous inflammation. Biochem Cell Biol 80, 103-107.
28. Kruzel ML, Harari Y, Mailman D, Actor JK, Zimecki M. 2002 Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice. Clin Exp Immunol 130, 25-31.
29. Lee WJ, Farmer JL, Hilty M, Kim YB. 1998 The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets. Infect Immun 66, 1421-1426.
30. Maaks S, Yan HZ, Wood WG. 1989 Development and evaluation of luminescence based sandwich assay for plasma lactoferrin as a marker for sepsis and bacterial infections in pediatric medicine. J Biolumines Chemilumines 3, 221-226.
31. Machnicki M, Zimecki M, Zagulski T. 1993 Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo. Int J Exp Pathol 74, 433-439.
32. Maneva AI, Sirakov LM, Manev VV. 1983 Lactoferrin binding to neutrophilic polymorphonuclear leucocytes. Int J Biochem 15, 981-984.
33. Mann DM, Romm E, Migliorini M. 1994 Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin. J Biol Chem 269, 23661-23667.
34. Masson PL, Heremans JF, Schonne E. 1969 Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J Exp Med 130, 643-658.
35. Mazurier J, Legrand D, Hu WL, Montreuil J, Spik G. 1989 Expression of human lactotransferrin receptors in phytohemagglutinin-stimulated human peripheral blood lymphocytes. Eur J Biochem 179, 481-487.
36. Mincheva-Nilsson L, Hammarstrom S, Hammarstrom ML. 1997 Activated human gamma delta T lymphocytes express functional lactoferrin receptors. Scand J Immunol 46, 609-618.
37. Miyauchi H, Hashimoto S, Nakajima M, Shinoda I, Fukuwatari Y, Hayasawa H. 1998 Bovine lactoferrin stimulates the phagocytic activity of human neutrophils: identification of its active domain. Cell Immunol 187, 34-37.
38. Miyazawa K, Mantel C, Lu L, Morrison DC, Broxmeyer HE. 1991 Lactoferrin-lipopolysaccharide interactions. Effect on lactoferrin binding to monocyte/macrophage-differentiated HL-60 cells. J Immunol 146, 723-729.
39. Montreuil J, Tonnelat J, Mullet S. 1960 Préparation et propriétés de la lactosidérophiline (lactotransferrine) du lait de femme. Biochim Biophys Acta 45, 413-121.
40. Rainard P. 1993 Activation of the classical pathway of complement by binding of bovine lactoferrin to unencapsulated Streptococcus agalactiae. Immunology 79, 648-652.
41. Sawatzki G, Rich IN. 1989 Lactoferrin stimulates colony stimulating factor production in vitro and in vivo. Blood Cells 15, 371-385.
42. Shau H, Kim A, Golub SH. 1992 Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin. J Leukoc Biol 51, 343-349.
43. Shimizu K, Matsuzawa H, Okada K et al. 1996 Lactoferrin-mediated protection of the host from murine cytomegalovirus infection by a T-cell-dependent augmentation of natural killer cell activity. Arch Virol 141, 1875-1889.
44. Shinoda I, Takase M, Fukuwatari Y, Shimamura S, Koller M, Konig W. 1996 Effects of lactoferrin and lactoferricin on the release of interleukin 8 from human polymorphonuclear leukocytes. Biosci Biotechnol Biochem 60, 521-523.
45. Sorimachi K, Akimoto K, Hattori Y, Ieiri T, Niwa A. 1997 Activation of macrophages by lactoferrin: secretion of TNF-α, IL-8 and NO. Biochem Mol Biol Int 43, 79-87.
46. Suzuki YA, Lönnerdal B. 2002 Characterization of mammalian receptors for lactoferrin. Biochem Cell Biol 80, 75-80.
47. Szuster-Ciesielska A, Kaminska T, Kandefer-Szerszen M. 1995 Phagocytosis-enhancing effect of lactoferrin on bovine peripheral blood monocytes in vitro and in vivo. Arch Vet Pol 35, 63-71.
48. Thomas LL, Xu W, Ardon TT. 2002 Immobilized lactoferrin is a stimulus for eosinophil activation. J Immunol 169, 993-999.
49. Togawa J, Nagase H, Tanaka K et al. 2002 Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. J Gastroenterol Hepatol 17, 1291-1298.
50. Wakabayashi H, Takakura N, Teraguchi S, Tamura Y. 2003 Lactoferrin feeding augments peritoneal macrophage activities in mice intraperitoneally injected with inactivated Candida albicans. Microbiol Immunol 47, 37-43.
51. Yamauchi K, Wakabayashi H, Hashimoto S, Teraguchi S, Hayasawa H, Tomita M. 1998 Effects of orally administered bovine lactoferrin on the immune system of healthy volunteers. Adv Exp Med Biol 443, 261-265.
52. Zagulski T, Lipinski P, Zagulska A, Broniek S, Jarzabek Z. 1989 Lactoferrin can protect mice against a lethal dose of E. coli in experimental infection in vivo. Br J Exp Pathol 70, 697-704.
53. Zhang GH, Mann DM, Tsai CM. 1999 Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide. Infect Immun 67, 1353-1358.
54. Zimecki M, Kocieba M, Kruzel M. 2002 Immunoregulatory activities of lactoferrin in the delayed type hypersensitivity in mice are mediated by a receptor with affinity to mannose. Immunobiology 205, 120-131.
55. Zimecki M, Mazurier J, Machnicki M, Wieczorek Z, Montreuil J, Spik G. 1991 Immunostimulatory activity of lactotransferrin and maturation of CD4- CD8-murine thymocytes. Immunol Lett 30, 119-123.
56. Zimecki M, Mazurier J, Spik G, Kapp JA. 1995 Human lactoferrin induces phenotypic and functional changes in murine splenic B cells. Immunology 86, 122-127.
57. Zweiman B, Kucich U, Shalit M et al. 1990 Release of lactoferrin and elastase in human allergic skin reactions. J Immunol 144, 3953-3960.